Generex Announces That It Will Not Exercise Its Rights to Issue and Sell Stock Under Its At Market Issuance Sales Agreement With WM Smith Until Further Notice Oct 30, 2009
Source: Generex Biotechnology Corp. ... Oct. 29, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq: - ) (), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that, in light of general market conditions, Generex will not exercise its right to issue and sell shares of its common stock under the At Market Issuance Sales Agreement that it entered into with Wm Smith & Co. on October 14, 2009 until further notice ... About... (Primezone Releases)
FDA Allows Emergency Use of Generex Diabetes Drug Sep 11, 2009
Generex Biotechnology Corp. said Thursday the Food and Drug Administration approved experimental use of its diabetes drug candidate Generex Oral-lyn. The FDA approved what is called a treatment investigational new drug program, which allows drug makers to make unapproved drug available to patients with dangerous illnesses who don't have a satisfactory treatment. (ABC News -- Wire)
Generex Biotechnology CEO Anna Gluskin Featured On BNN News to Discuss Potential for H1N1 Vaccine Aug 25, 2009
Source: Generex Biotechnology Corp. ... Aug. 24, 2009 (GLOBE NEWSWIRE) -- Anna E. Gluskin, the chairman, president and CEO of Generex Biotechnology Corporation (Nasdaq: - ; ), was featured this morning on "Market News" on Canada's Business News Network (BNN) to discuss the current circumstances of H1N1 and how Generex's synthetic vaccine platform can respond to the swine flu's ever-changing DNA. The segment can be viewed online at and will be available later today at www ... About Generex... (Primezone Releases)
Today's hottest alerts include: INFY, YHOO, AAPL, VNDA, GNBT, MSFT May 23, 2009
Inc (NASDAQ:), Apple Inc (NASDAQ:), Vanda Pharmaceuticals Inc (NASDAQ:), Generex Biotechnology Group (NASDAQ:), Microsoft Corp (NASDAQ:). UnrealStocks. (PR Newswire)
Generex Biotechnology Announces Consummation of $5 Million Registered Direct Offering of Common Stock May 16, 2009
Press Release Source: Generex Biotechnology Corp. ... May 15, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (NasdaqCM: - ) (), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it has consummated a registered direct offering of 15,151,517 shares of its common stock to a select group of accredited investors at $0 ... About Generex Biotechnology Corporation. (Primezone Releases)
Why We Love Wild Penny Stocks Mar 15, 2009
Just take a look at the returns from Generex Biotechnology (Nasdaq: GNBT) and MIVA (Nasdaq: MIVA), each of which have quickly doubled this month. Those $0. (MSNBC -- Business)
